| DFFN Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the DFFN shares outstanding history going back to 8/19/2016:
Also see: DFFN Market Cap History DFFN YTD Return |
DFFN Shares Outstanding History — Diffusion Pharmaceuticals Share Count Over Time
As of 8/7/2023 Diffusion Pharmaceuticals has 1.36 million DFFN shares outstanding. Investors often track the DFFN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows DFFN share count trends over time, with 31 historical shares outstanding datapoints presented, dating back to 8/19/2016.
| DFFN Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
DFFN Historical Shares Outstanding: +104.80% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| DFFN Stock Price Chart |
| About CervoMed Inc |
| Diffusion Pharmaceuticals is a clinical stage biotechnology company. Co. is developing its primary product candidate, transcrocetinate sodium, also known as trans sodium crocetinate (TSC). TSC is designed to selectively target and re-oxygenate the micro-environment of hypoxic cells, and can potentially be used in various indications, including stroke, oncology and cardiovascular disease. Co.'s oncology program targets TSC against treatment-resistant brain cancer. In addition to the TSC programs, Co. is exploring alternatives to capitalize upon its product candidate RES-529, a PI3K/Akt/mTOR pathway inhibitor for age-related macular degeneration. We show 31 historical shares outstanding datapoints in our coverage of DFFN's shares outstanding history. Understanding the changing numbers of DFFN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like DFFN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching DFFN by allowing them to research DFFN shares outstanding history as well as any other stock in our coverage universe. |
| DFFN Current Stock Quote |
Quotes delayed 20 minutes  Free DFFN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| DFFN Share Performance |
| Shares Outstanding Peers |
| Diffusion Pharmaceuticals (DFFN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
DFTX Shares Outstanding History DGX Shares Outstanding History DHR Shares Outstanding History DICE Shares Outstanding History DMK Shares Outstanding History DMPI Shares Outstanding History DMRA Shares Outstanding History DMTK Shares Outstanding History DNAY Shares Outstanding History DNLI Shares Outstanding History More Healthcare companies » |
DFFN Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
